SEC Form 4 · accession 0001127602-17-001707

Salesforce, Inc. · CRM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman of the Board and CEO · Director

Period of report

Jan 12, 2017

Accepted (ET)

Jan 13, 2017 · 7:52 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001108524

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 12, 2017	M	10,000	$39.0925	A	34,155,500	D
Common Stock^F2	Jan 12, 2017	S	5,099	$74.5884	D	34,150,401	D
Common Stock^F3	Jan 12, 2017	S	4,901	$75.1878	D	34,145,500	D
Common Stock	Jan 13, 2017	M	10,000	$39.0925	A	34,155,500	D
Common Stock^F4	Jan 13, 2017	S	10,000	$75.4203	D	34,145,500	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-qualified Stock Option (Right to Buy)^F5	$39.0925	Jan 12, 2017	M	10,000	D	Nov 27, 2013	Nov 27, 2017	Common Stock	10,000	1,420,000	D
Non-qualified Stock Option (Right to Buy)^F5	$39.0925	Jan 13, 2017	M	10,000	D	Nov 27, 2013	Nov 27, 2017	Common Stock	10,000	1,410,000	D

F1Pursuant to a 10b5-1 Plan.
F2Weighted average price. These shares were sold in multiple transactions at prices ranging from $74.0500 to $74.9800 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3Weighted average price. These shares were sold in multiple transactions at prices ranging from $75.0500 to $75.3500 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4Weighted average price. These shares were sold in multiple transactions at prices ranging from $74.8700 to $75.7600 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5Option is exercisable and vests over four years at the rate of 25% on November 27, 2013, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.